Unlock precision and clarity in alternative investments with Dynamo Software, a cloud-native, AI-powered platform that unifies your entire workflow. We provide a single, configurable solution for your front-, middle-, and back-office needs.
For General Partners (GPs), Dynamo enhances every stage of the investment lifecycle with advanced CRM, deal pipeline tracking, fundraising tools, and secure investor relations and fund accounting reporting.
For Limited Partners (LPs), our platform delivers real-time research and portfolio management capabilities. We automate document ingestion, data extraction, and holdings enrichment, providing deep exposure analytics for informed decision-making.
Dynamo serves a wide range of private capital firms, including private equity, venture capital, real estate, hedge funds, and infrastructure. Our platform is also tailored for endowments, pensions, foundations, family offices, fund of funds, and fund administrators. By centralizing all investment data into a single source of truth, we equip your team with the control needed to uncover powerful insights.
Our AI-driven system automates data ingestion and tagging, while our HoldingsInsight feature enriches portfolio data for advanced analysis. All modules work together seamlessly, supported by a dedicated Client Services team committed to your success. With Dynamo, you can streamline operations, improve data accuracy, and drive strategic decisions with confidence.
Learn more
Experience substantial profits while minimizing your risk to market fluctuations. Utilize our meticulous due diligence and strategic partnerships with your investment funds. Unlock access to high-quality institutional opportunities across diverse asset classes. Participate in carefully vetted private equity deals. Enjoy passive income that is deposited directly into your bank account. Monitor your investments effortlessly through our top-tier investor portal. Unlike typical crowdfunding platforms, we operate as a technology-driven real estate investment company. Our compensation structure is heavily aligned with the success of our assets, and we actively invest in every offering we present, ensuring we share in the journey of our investors. By prioritizing performance, we create a win-win scenario for both the firm and our clients.
Learn more
Bipsync
Bipsync unifies your complete research workflow into a single, cohesive, and user-friendly platform. Demonstrated to improve efficiency, foster teamwork, and streamline compliance, the Bipsync Research Management Platform is meticulously crafted to assist professional investors in effectively overseeing and expediting their research endeavors, ensuring they stay ahead in a competitive market.
Learn more
FinMonkeys
FinMonkeys is an innovative platform that leverages artificial intelligence to deliver financial research and market analysis tailored for investors, traders, finance creators, and those focused on research.
This platform enables users to navigate through the complexities of the market by offering comprehensive analysis of financial news, stock sentiment, macroeconomic indicators, charts, SEC filings, as well as data on ETFs, mutual funds, institutional movements, and market catalysts, all within a single research environment.
FinMonkeys features a variety of tools, including the Market News Analyzer, Social Analyzer, Leading Indicators, Chart Analysis, Hot Money Tracker, ETF Tools, SEC Filings, and Catalyst Radar, all designed to enhance the speed of investment research, improve market comprehension, and facilitate more informed analysis.
While FinMonkeys serves as a valuable resource for research and insights, it does not engage in trade execution or offer personalized financial advice. Instead, it equips users with research tools, AI-generated summaries, sentiment analysis, contextual market insights, and data-driven evaluations to empower them in making independent investment choices.
Ultimately, FinMonkeys aims to transform the way users approach financial research by making it more accessible and efficient.
Learn more
